These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 36756834)

  • 1. [Progress in active surveillance for adult low-risk papillary thyroid microcarcinoma].
    Liu J; Xu C; Yao X; Zhao R; Zhang S
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2023 Feb; 37(2):150-156. PubMed ID: 36756834
    [No Abstract]   [Full Text] [Related]  

  • 2. Indications and Strategy for Active Surveillance of Adult Low-Risk Papillary Thyroid Microcarcinoma: Consensus Statements from the Japan Association of Endocrine Surgery Task Force on Management for Papillary Thyroid Microcarcinoma.
    Sugitani I; Ito Y; Takeuchi D; Nakayama H; Masaki C; Shindo H; Teshima M; Horiguchi K; Yoshida Y; Kanai T; Hirokawa M; Hames KY; Tabei I; Miyauchi A
    Thyroid; 2021 Feb; 31(2):183-192. PubMed ID: 33023426
    [No Abstract]   [Full Text] [Related]  

  • 3. Active Surveillance Versus Immediate Surgery: Questionnaire Survey on the Current Treatment Strategy for Adult Patients with Low-Risk Papillary Thyroid Microcarcinoma in Japan.
    Sugitani I; Ito Y; Miyauchi A; Imai T; Suzuki S
    Thyroid; 2019 Nov; 29(11):1563-1571. PubMed ID: 31441377
    [No Abstract]   [Full Text] [Related]  

  • 4. Papillary thyroid microcarcinoma: Is active surveillance always enough?
    Sutherland R; Tsang V; Clifton-Bligh RJ; Gild ML
    Clin Endocrinol (Oxf); 2021 Dec; 95(6):811-817. PubMed ID: 34021503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Active Surveillance as an Effective Management Option for Low-Risk Papillary Thyroid Microcarcinoma.
    Jeon MJ; Kim WG; Kim TY; Shong YK; Kim WB
    Endocrinol Metab (Seoul); 2021 Aug; 36(4):717-724. PubMed ID: 34379969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Active surveillance of low-risk papillary thyroid microcarcinomas in Japan and other countries: a review.
    Ito Y; Miyauchi A
    Expert Rev Endocrinol Metab; 2020 Jan; 15(1):5-12. PubMed ID: 31902250
    [No Abstract]   [Full Text] [Related]  

  • 7. Active surveillance vs. surgery in low-risk papillary thyroid microcarcinoma patients and the risk of loss to follow-up.
    Saito Y; Matsuzu K; Takami H; Matsui A; Kuga Y; Ohara R; Yoshioka K; Masaki C; Akaishi J; Hames KY; Okamura R; Tomoda C; Suzuki A; Kitagawa W; Nagahama M; Sugino K; Ito K
    Cancer Med; 2024 Aug; 13(16):e70123. PubMed ID: 39194351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progression of Low-Risk Papillary Thyroid Microcarcinoma During Active Surveillance: Interim Analysis of a Multicenter Prospective Cohort Study of Active Surveillance on Papillary Thyroid Microcarcinoma in Korea.
    Lee EK; Moon JH; Hwangbo Y; Ryu CH; Cho SW; Choi JY; Chung EJ; Jeong WJ; Jung YS; Ryu J; Kim SJ; Kim MJ; Kim YK; Lee CY; Lee JY; Yu HW; Hah JH; Lee KE; Lee YJ; Park SK; Park DJ; Kim JH; Park YJ
    Thyroid; 2022 Nov; 32(11):1328-1336. PubMed ID: 36205563
    [No Abstract]   [Full Text] [Related]  

  • 9. Position paper from the Japan Thyroid Association task force on the management of low-risk papillary thyroid microcarcinoma (T1aN0M0) in adults.
    Horiguchi K; Yoshida Y; Iwaku K; Emoto N; Kasahara T; Sato J; Shimura H; Shindo H; Suzuki S; Nagano H; Furuya F; Makita N; Matsumoto F; Manaka K; Mitsutake N; Miyakawa M; Yokoya S; Sugitani I
    Endocr J; 2021 Jul; 68(7):763-780. PubMed ID: 33762511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Active surveillance as a management strategy for papillary thyroid microcarcinoma.
    Zhang H; Zheng X; Liu J; Gao M; Qian B
    Cancer Biol Med; 2020 Aug; 17(3):543-554. PubMed ID: 32944389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Papillary thyroid microcarcinoma: how to diagnose and manage this epidemic?
    Soares P; Celestino R; Gaspar da Rocha A; Sobrinho-Simões M
    Int J Surg Pathol; 2014 Apr; 22(2):113-9. PubMed ID: 24401191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BRAF V600E status may facilitate decision-making on active surveillance of low-risk papillary thyroid microcarcinoma.
    Kim KJ; Kim SG; Tan J; Shen X; Viola D; Elisei R; Puxeddu E; Fugazzola L; Colombo C; Jarzab B; Czarniecka A; Lam AK; Mian C; Vianello F; Yip L; Riesco-Eizaguirre G; Santisteban P; O'Neill CJ; Sywak MS; Clifton-Bligh R; Bendlova B; Sýkorová V; Xing M
    Eur J Cancer; 2020 Jan; 124():161-169. PubMed ID: 31790974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-risk papillary microcarcinoma of the thyroid: A review of active surveillance trials.
    Ito Y; Miyauchi A; Oda H
    Eur J Surg Oncol; 2018 Mar; 44(3):307-315. PubMed ID: 28343733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Active surveillance for adult low-risk papillary thyroid microcarcinoma-a review focused on the 30-year experience of Kuma Hospital.
    Ito Y; Miyauchi A; Fujishima M; Yamamoto M; Sasaki T
    Endocr J; 2024 Jan; 71(1):7-21. PubMed ID: 37793883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor growth manifested in two-fifths of low-risk papillary thyroid microcarcinoma patients during active surveillance: data from a tertiary center in China.
    Le K; Jin L; Zhong F; Huang X; Zhou L; Zhou J; Xie L
    Front Endocrinol (Lausanne); 2024; 15():1359621. PubMed ID: 38577570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-Term Outcomes of Active Surveillance and Immediate Surgery for Adult Patients with Low-Risk Papillary Thyroid Microcarcinoma: 30-Year Experience.
    Miyauchi A; Ito Y; Fujishima M; Miya A; Onoda N; Kihara M; Higashiyama T; Masuoka H; Kawano S; Sasaki T; Nishikawa M; Fukata S; Akamizu T; Ito M; Nishihara E; Hisakado M; Kosaka K; Hirokawa M; Hayashi T
    Thyroid; 2023 Jul; 33(7):817-825. PubMed ID: 37166389
    [No Abstract]   [Full Text] [Related]  

  • 17. Active Surveillance of Thyroid Microcarcinoma-Can This Approach Be Safely Implemented Worldwide?
    Pollack R; Mazeh H
    J Surg Res; 2021 Feb; 258():145-152. PubMed ID: 33010560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Active Surveillance of Thyroid Microcarcinomas: a Critical View.
    Cernea CR; Matos LL; Eugênio C; Ferreira GM; Cerqueira YS; Leite AKN; Vanderlei FAB; de Carlucci D; Gotoda RN; Hojaij FC; Araújo-Filho VJF
    Curr Oncol Rep; 2022 Jan; 24(1):69-76. PubMed ID: 35061193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mortality rate and causes of death in papillary thyroid microcarcinoma.
    Heo J; Ryu HJ; Park H; Kim TH; Kim SW; Oh YL; Chung JH
    Endocrine; 2024 Mar; 83(3):671-680. PubMed ID: 37814113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Retrospective comparison of screening criteria for active surveillance for papillary thyroid microcarcinoma].
    Qian K; Sun TQ; Guo K; Zheng XK; Li DS; Wei WW; Wu Y; Ji QH; Wang ZY
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jun; 52(6):430-434. PubMed ID: 28635215
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.